share_log

Piper Sandler Initiates Coverage On Galera Therapeutics With Overweight Rating, Announces Price Target of $6

Benzinga Real-time News ·  Feb 21, 2023 18:10

Piper Sandler analyst Edward Tenthoff initiates coverage on Galera Therapeutics (NASDAQ:GRTX) with a Overweight rating and announces Price Target of $6.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment